Anti-neoplastic Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Anti-neoplastic Market is estimated to be USD XX million in 2018 and predicted to rise to USD xx billion by 2023with a CAGR of xx%. The market is segmented by product type (personalized medicine, biological agents and chemotherapeutic agents) , by end user( hospitals, clinics, cancer rehabilitation centers and ambulatory surgical centers) . Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
Rising number of people being diagnosed with cancer and the demand for affordable treatments for the same are the major drivers driving the market growth. Due to the recent advancements in personalised medicines the market is expected to propel during the forecast period. However, the high manufacturing costs of anti-neoplastic agents is the major factor hampering the market growth.
The market for Anti-neoplastic Agents is broadly categorized into product type and end user. By product type the market is divided into personalized medicine, biological agents and chemotherapeutic agents. Chemotherapeutic agents account for a major share of the market revenue. By end user the market is segmented into hospitals, clinics, cancer rehabilitation centers and ambulatory surgical centers. Hospitals segment dominated a major share of the market revenue. On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Anti-neoplastic Agents market was dominated by North America closely followed Europe. Asia Pacific is expected to grow at a high CAGR.
Some of the major companies dominating the market, by their products and services include Aspen Global Inc., Bayer AG, Teva pharmaceutical Industries Ltd., Johnson & Johnson Pvt. Ltd., Merc & Co., Inc., Pfize Inc., Hoffmann-La Roche Ltd., Amgen Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Boehringer Ingelheim GmbH, Accord Healthcare, Inc., Genentech, Inc., Lundbeck LLC, AbbVie Inc.
Browse through the full report at “https://www.marketdataforecast.com/market-reports/anti-neoplastic-agents-market-8315/” and checkout our recent reports in the Healthcare category at “https://www.marketdataforecast.com/category/healthcare-1/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.